We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $5.3M Turnover 85.61%
1-Year Est. Return 7.8%
This Fund
S&P 500
This Quarter Est. Return
-7.09%
1 Year Est. Return
+7.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
Cap. Flow
-$186M
Cap. Flow %
-1,882.29%
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Avg Time Held
0.3 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
ACVA icon
ACV Auctions
ACVA
+$194K
2
RPD icon
Rapid7
RPD
+$183K
3
EFC icon
Ellington Financial
EFC
+$181K
4
SAN icon
Banco Santander
SAN
+$159K
5
OSCR icon
Oscar Health
OSCR
+$155K

Top Sells

Rank Stock Value
1
EXLS icon
EXL Service
EXLS
+$830K
2
DK icon
Delek US
DK
+$724K
3
AVGO icon
Broadcom
AVGO
+$669K
4
ITRI icon
Itron
ITRI
+$666K
5
EAT icon
Brinker International
EAT
+$649K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.83%
2 Technology 15.87%
3 Healthcare 10.98%
4 Industrials 10.86%
5 Real Estate 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ACEL icon
101
Accel Entertainment
ACEL
$883M
– –
-12,817
Closed -$146K –
ACI icon
102
Albertsons Companies
ACI
$6.35B
– –
-19,323
Closed -$332K –
ACIC icon
103
American Coastal Insurance
ACIC
$525M
– –
-16,091
Closed -$203K –
ACRE icon
104
Ares Commercial Real Estate
ACRE
$191M
– –
-26,066
Closed -$125K –
ADSK icon
105
Autodesk
ADSK
$50.1B
– –
-900
Closed -$266K –
AEM icon
106
Agnico Eagle Mines
AEM
$96B
– –
-1,775
Closed -$301K –
AEP icon
107
American Electric Power
AEP
$69.2B
– –
-1,775
Closed -$205K –
AES icon
108
AES
AES
$10.7B
– –
-14,625
Closed -$210K –
AEVA icon
109
Aeva Technologies
AEVA
$699M
– –
-10,662
Closed -$142K –
AFL icon
110
Aflac
AFL
$60.1B
– –
-3,331
Closed -$367K –
AG icon
111
First Majestic Silver
AG
$7.88B
– –
-18,004
Closed -$300K –
AIP icon
112
Arteris
AIP
$922M
– –
-20,655
Closed -$320K –
AIV icon
113
Aimco
AIV
$247M
– –
-45,442
Closed -$270K –
AL icon
114
DELISTED
Air Lease Corp
AL
– –
-3,755
Closed -$241K –
ALHC icon
115
Alignment Healthcare
ALHC
$1.72B
– –
-18,122
Closed -$358K –
ALKT icon
116
Alkami Technology
ALKT
$1.47B
– –
-11,581
Closed -$267K –
ALLT icon
117
Allot
ALLT
$445M
– –
-35,604
Closed -$350K –
ALLY icon
118
Ally Financial
ALLY
$11.5B
– –
-5,860
Closed -$265K –
ALNY icon
119
Alnylam Pharmaceuticals
ALNY
$31B
– –
-504
Closed -$200K –
AMD icon
120
Advanced Micro Devices
AMD
$863B
– –
-1,116
Closed -$239K –
AMP icon
121
Ameriprise Financial
AMP
$44.2B
– –
-665
Closed -$326K –
AMPX icon
122
Amprius Technologies
AMPX
$1.13B
– –
-42,991
Closed -$339K –
AMSF icon
123
AMERISAFE
AMSF
$468M
– –
-8,760
Closed -$336K –
AMX icon
124
America Movil
AMX
$68.4B
– –
-13,869
Closed -$287K –
ANET icon
125
Arista Networks
ANET
$223B
– –
-1,883
Closed -$247K –

Similar funds

PharVision Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.

  • PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
  • PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
  • PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
  • PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
  • PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
  • PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
  • PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.